In Gaucher disease, a lysosomal storage disorder linked to malignant cancers, the accumulation of glucosylceramide and inflammatory response is regulated by the classical pathway-dependent complement activation through C5a–C5aR1 signaling [129,130]. Here, C5AR1 is linked to lysosomal storage disease.